Skip to content

A clinical study to compare Talisadi Tablets and Navayasa Loha Tablets for Increasing Haemoglobin Levels in Pregnant Women with Anaemia.

An open label double arm randomised clinical study to compare the efficacy of talisadi gutika and navayasa loha in garbhini pandu w.s.r anaemia in pregnancy. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108428
Enrollment
20
Registered
2026-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

Dr Gayathri P M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hb percentage more than 7 and less than 11gm percentage Patients between age group of 18 to 35 years Patients of second and third trimesters Primigravida and multigravida Patients presenting with any 3 symptoms mentioned in diagnostic criteria with Hb percentage more than 7 and less than 11gm percentage

Exclusion criteria

Exclusion criteria: Patients of first trimester. Patients diagnosed with anaemia due to thalassemia, sickle cell anaemia, haemolytic anaemia, aplastic anaemia,pernicious anemia. Patients diagnosed with Bleeding piles,Multiple pregnancy,Antepartum haemorrhage. Patients diagnosed with gestational diabetes, pregnancy induced hypertension which interfere with the course of treatment.

Design outcomes

Primary

MeasureTime frame
To asses the reduction in Panduta,Annadwesha,Shrama,Bhrama, Dourbalya and other parameters in two treatment modalities viz talisadi gutika and navayasa loha in Garbhini Pandu wsr to anaemia in pregnancy. Timepoint: 1year 6months

Secondary

MeasureTime frame
nillTimepoint: not applicable

Countries

India

Contacts

Public ContactDR Anupama V

Sri kalabyaraveshwara swamy ayurvedic medical college

dr.anupama.v@gmail.com9845442660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026